LCS
MJN

Levin Capital Strategies’s Mead Johnson Nutrition Company MJN Stock Holding History

Levin Capital Strategies’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-8,469
Closed -$754K – 357
2017
Q1 		$754K Buy
+8,469
New +$697K 0.01% 168
2016
Q3 		– Sell
-2,500
Closed -$227K – 384
2016
Q2 		$227K Sell
2,500
-1,500
-38% -$127K ﹤0.01% 296
2016
Q1 		$340K Buy
+4,000
New +$298K 0.01% 262

Other funds holding MJN

PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
FNBOO
First National Bank of Omaha Omaha, Nebraska $3.55B AUM 27.24% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Levin Capital Strategies's MJN Position: Q2 2017 in Review

Levin Capital Strategies sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 8,469 shares — an estimated $754K sold.

Levin Capital Strategies first reported a position in MJN in Q1 2016 and held it in 3 quarters. The position peaked at $754K in Q1 2017. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Levin Capital Strategies reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Levin Capital Strategies sold 8,469 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $754K.
  • Levin Capital Strategies first reported a position in Mead Johnson Nutrition Company in Q1 2016 and held it in 3 quarters.
  • Levin Capital Strategies's Mead Johnson Nutrition Company position peaked at $754K in Q1 2017.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Levin Capital Strategies's 13F filing for Q2 2017, filed 11 Aug 2017.